Bicara Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-98.8M | $4.2M |
| Mar 2023 | — | $-105.9M | — |
| Jun 2023 | — | $-114.8M | — |
| Sep 2023 | — | $-137.1M | $44.2M |
| Dec 2023 | — | $-148.8M | $230.4M |
| Mar 2024 | — | $-160.1M | $216.0M |
| Jun 2024 | — | $-174.8M | $203.9M |
| Sep 2024 | — | $509.6M | $520.8M |
| Dec 2024 | — | $491.9M | $489.7M |
| Mar 2025 | — | $459.0M | $462.1M |
| Jun 2025 | — | $435.2M | $436.6M |
| Sep 2025 | — | $402.8M | $171.7M |
| Dec 2025 | — | $401.5M | $96.7M |
| Mar 2026 | — | $514.0M | $323.5M |
| Jun 2026 | — | $468.8M | $96.6M |